ZEALAND PHARMA A/S |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 921.50 DKK | +2.96% |
|
+2.33% | +147.05% |
| 09-09 | Zealand Pharma's Weight Management Drug Shows Positive Topline Results in Early-stage Trial | MT |
| 09-09 | Zealand Pharma Weight Loss Treatment Trial Shows up to 8.3% Reduction in Body Weight | MT |
EPS & Dividend: Zealand Pharma A/S
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -16.91 | -22.07 | -23.75 | -26.02 | -12.44 | -11.29 | -7.966 | -6.03 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 235.40 | 220.60 | 145.10 | 201.40 | 373.20 | 895.00 | 895.00 | 895.00 |
| Nbr of stocks (in thousands) | 35,990 | 39,735 | 43,216 | 51,470 | 58,374 | 70,946 | - | - |
| Announcement Date | 20-03-11 | 21-03-11 | 22-03-10 | 23-03-01 | 24-02-27 | - | - | - |
1DKK in Million2DKK
Estimates
Upcoming events: Zealand Pharma A/S
More events
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -79.26x | 6.525 | 116.96x | ||
| -.--% | -.--% | -239.26x | 7.455 | 10.46x | ||
| -.--% | -.--% | 30.56x | 4.206 | 8.03x | ||
| -.--% | -.--% | -516.33x | 7.224 | 14.17x | ||
| -.--% | -.--% | -42.76x | 1.269 | 4.53x | ||
| -.--% | -.--% | -33.02x | 6.292 | 5.32x | ||
| - | - | - | - | - | ||
| -.--% | -.--% | 21.33x | 3.366 | 4.19x | ||
| +2.41% | +2.61% | 12.18x | 1.892 | 2.59x | ||
| -.--% | -.--% | -26.01x | - | - | ||
| Average | +0.27% | +0.29% | -96.95x | 4.78 | 20.78x | |
| Weighted average by Cap. | +0.10% | +0.11% | -115.78x | 5.35 | 11.29x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition